Smartphones May Bolster Postoperative Recovery...
A Mass General researcher is co-leading an effort to determine whether data gathered with smartphones can help provide a clearer picture of recovery after surgery.
Genomics Researchers Elevated by Collaboration...
Mass General researchers have become pivotal players in the emergence of precision medicine due to their local and international leadership in genomics.
Chest X-rays May Provide New Health Risk Clues...
Mass General researchers are using artificial-intelligence to analyze standard chest x-rays to predict patients’ future risk of a variety of disorders.
Measles: Protection Key to Stopping Outbreaks...
An infectious disease specialist at Mass General says vaccinations have made measles a rarity in the United States, although risks remain.
Can Beauty Salons Help Deliver Health Services?...
A Weissman Family MGH Research Scholar is exploring whether beauty salons in South Africa can help to prevent unwanted pregnancies and stop the spread of HIV.
Study Helps Improve Neonatal Feeding Strategies...
The Neonatal Intensive Care Unit at the MassGeneral Hospital for Children has adopted a new process for transitioning premature infants to oral feeding.
ALS: Rare Form of Disease Studied for Clues...
A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.
Researcher Explores Microbiome Links to Allergies...
In search of how children develop severe allergies and autoimmune disorders, Nitya Jain, PhD, at MassGeneral Hospital for Children, is studying how the immune system’s T cells communicate with bacteria in the gut.
Multiple Sclerosis Care Advances but Work Remains...
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
Neurofibromatosis Research Reflects Clinic-Lab Link...
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.